Zacks Research Issues Negative Estimate for CRL Earnings
Charles River Laboratories International, Inc. (NYSE:CRL – Free Report) – Equities research analysts at Zacks Research reduced their Q3 2025 earnings per share (EPS) estimates for shares of Charles River Laboratories International in a report issued on Wednesday, May 28th. Zacks Research analyst R. Department now forecasts that the medical research company will earn $2.37 […]
Charles River Laboratories International, Inc. (NYSE:CRL – Free Report) – Equities research analysts at Zacks Research reduced their Q3 2025 earnings per share (EPS) estimates for shares of Charles River Laboratories International in a report issued on Wednesday, May 28th. Zacks Research analyst R. Department now forecasts that the medical research company will earn $2.37 […]
